When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LGND - Goldman provides color on $168/share target on Ligand Pharma
Ligand Pharmaceuticals Incorporated
Goldman Sachs analyst Dana Flanders provides the numbers behind his Street-low fair value target of $168 (46% upside) for Ligand Pharmaceuticals (LGND-2.1%) which makes money via licensing deals.
More news on: Ligand Pharmaceuticals Incorporated, Healthcare stocks news, Stocks on the move,